The US irritable bowel syndrome treatment market is expected to reach US$ 1,276.21 Mn in 2027 from US$ 586.61 Mn in 2019. The market is estimated to grow with a CAGR of 10.3% from 2020-2027.
The growth of the market is driven by the factors such as, increasing prevalence of irritable bowel syndrome and associated conditions, and increasing numbers of FDA approvals & drug developments. On the other hand, limited number of product availability and treatment inefficiency is likely to restraint the growth of market during the forecast years.
Irritable Bowel Syndrome treatment market is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.
Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. According to data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated have 25% severe IBS. Many people don't recognize IBS symptoms. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are some of the risk factors which are causing irritable bowel syndrome. These factors are projected to accelerate the rate of prevalence of irritable bowel syndrome across the globe. For instance, according to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of irritable bowel syndrome is likely to boost the US irritable bowel syndrome treatment market during the forecast period.
In order to cope up against irritable bowel syndrome in the country, the companies involved in the drug development for irritable bowel syndrome are taking constructive steps to implement awareness programs with an aim to spread awareness amongst the populations. For instance, in 2018, the collaboration of Allergan PLC and Ironwood launched an Interactive Digital Destination platform to encourage sufferers to get educated and take action. Such initiatives are also anticipated to drive the demand for irritable bowel syndrome treatment market in US.
US Irritable Bowel Syndrome Treatment - Market Segmentation
US Irritable Bowel Syndrome Treatment Market - By Type
US Irritable Bowel Syndrome Treatment Market - By Product
US Irritable Bowel Syndrome Treatment Market - By Distribution Channel
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 586.61 Million |
| Market Size by 2027 | US$ 1,276.21 Million |
| CAGR (2020 - 2027) | 10.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
United States
|
| Market leaders and key company profiles |
|
The US Irritable Bowel Syndrome Treatment Market is valued at US$ 586.61 Million in 2019, it is projected to reach US$ 1,276.21 Million by 2027.
As per our report US Irritable Bowel Syndrome Treatment Market, the market size is valued at US$ 586.61 Million in 2019, projecting it to reach US$ 1,276.21 Million by 2027. This translates to a CAGR of approximately 10.3% during the forecast period.
The US Irritable Bowel Syndrome Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Irritable Bowel Syndrome Treatment Market report:
The US Irritable Bowel Syndrome Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Irritable Bowel Syndrome Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Irritable Bowel Syndrome Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For US Irritable Bowel Syndrome Treatment Market
